Skip to main content
Log in

Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF–producing multiple myeloma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, Nishi T, Amano Y (1995) Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 55:3438–3443

    CAS  PubMed  Google Scholar 

  2. Kyo S, Kanaya T, Takakura M, Inoue M (2000) A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6. Gynecol Oncol 78:383–387

    Article  CAS  Google Scholar 

  3. Savarese TM, Mitchell K, McQuain C, Campbell CL, Guardiani R, Wuu J, Ollari C, Reale F, Nelson BE, Chen A, Quesenberry PJ (2001) Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Lett 162:105–115

    Article  CAS  Google Scholar 

  4. Connor JP (2006) Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: case report and laboratory correlates. Gynecol Oncol 103:349–353

    Article  Google Scholar 

  5. Usuda H, Naito M, Ohyach K, Iizumi T (1997) A case of multiple myeloma producing granulocyte colony-stimulating factor. Pathol Int 47:866–869

    Article  CAS  Google Scholar 

  6. Kohmura K, Miyakawa Y, Kameyama K, Kizaki M, Ikeda Y (2004) Granulocyte colony stimulating factor-producing multiple myeloma associated with neutrophilia. Leuk Lymphoma 45:1475–1479

    Article  CAS  Google Scholar 

  7. Kusaba N, Yoshida H, Ohkubo F, Mishima K, Shimamastu K, Okamura T, Sata M (2004) Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia. Rinsho Ketsueki 45:228–232 (in Japanese)

    PubMed  Google Scholar 

  8. Nagai M, Oda S, Iwamoto M, Marumoto K, Fujita M, Takahara J (1996) Granulocyte-colony stimulating factor concentrations in a patient with plasma cell dyscrasia and clinical features of chronic neutrophilic leukaemia. J Clin Pathol 49:858–860

    Article  CAS  Google Scholar 

  9. de la Rubia J, Bonanad S, Palau J, Sanz GF, Sanz MA (1994) Rapid progression of multiple myeloma following G-CSF mobilization. Bone Marrow Transplant 14:475–476

    PubMed  Google Scholar 

  10. Meropol NJ, Miller LL, Korn EL, Braitman LE, MacDermott ML, Schuchter LM (1992) Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst 84:1201–1203

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Taku Kikuchi.

Ethics declarations

Conflict of interest

TM received personal fees from Janssen Pharma, Takeda Pharmaceutical, and Kyowa Kirin. The remaining authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patient included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kikuchi, T., Kato, J., Koda, Y. et al. Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF–producing multiple myeloma. Ann Hematol 99, 1667–1668 (2020). https://doi.org/10.1007/s00277-020-04120-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04120-4

Navigation